person · Reporting owner
Caple Frederick William
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Endovia Health Sciences, Inc.SBEV · Entity 8508 | Director | June 08, 2026 | June 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Endovia Health Sciences, Inc.
Report date June 08, 2026 · Filed June 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.25 · Expires 2036-06-08 | Direct | 500,000 |
Reported balance
After 2026-06-08 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-08 · Grant · Acquired 500,000 · Balance 500,000 F1: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 08, 2026 Filed Jun 10, 2026 20:31 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | GrantStock Options (Right to Buy) · Derivative | 500,000 | Not disclosed Strike: $0.25 | Not disclosed |
DisclosureSEC source: 0001731122-26-000835 · ownership.xml · derivative · entry 1 Caple Frederick William · CIK 0001978199 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2036-06-08 F1 · security: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested. F1 · price: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested. F1 · derivative.exercise_date: The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested. Read SEC document |
| July 31, 2025 Filed Oct 20, 2025 20:20 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | GrantWarrants · Derivative | 750,000 | Not disclosed Strike: $0.80 | Not disclosed |
DisclosureSEC source: 0001731122-25-001406 · ownership.xml · derivative · entry 1 Caple Frederick William · CIK 0001978199 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · SNS Universal Solutions LLC Disclosed balance after: 750,000 Underlying: Common Stock · 750,000 shares Expires 2030-07-31 F1 · security: The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested. F1 · price: The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested. F2 · ownership.nature: SNS Universal Solutions LLC is an entity which the Reporting Person controls. Read SEC document |
| April 19, 2024 Filed Oct 20, 2025 20:15 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | GrantStock Options (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $13.60 | $0.00 |
DisclosureSEC source: 0001731122-25-001405 · ownership.xml · derivative · entry 2 Caple Frederick William · CIK 0001978199 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · SNS Universal Solutions LLC Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-04-19 F2 · security: The stock options shall be exercisable for a 3-year period, and shall vest as follows: 75,000 immediately (125,000 already vested) and 50,000 per quarter for the next 8 quarters. F3 · security: Gives effect to a reverse stock split of 1-for-40 effective March 27, 2025. F1 · derivative.exercise_date: The grant of the Issuer's restricted common stock was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The shares of restricted common stock are fully vested. F4 · ownership.nature: SNS Universal Solutions LLC is an entity which the Reporting Person controls. Read SEC document |
| April 19, 2024 Filed Oct 20, 2025 20:15 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | GrantCommon Stock | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001731122-25-001405 · ownership.xml · nonDerivative · entry 1 Caple Frederick William · CIK 0001978199 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · SNS Universal Solutions LLC Disclosed balance after: 1,875 F1 · security: The grant of the Issuer's restricted common stock was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The shares of restricted common stock are fully vested. F3 · shares: Gives effect to a reverse stock split of 1-for-40 effective March 27, 2025. F3 · balance_after: Gives effect to a reverse stock split of 1-for-40 effective March 27, 2025. F4 · ownership.nature: SNS Universal Solutions LLC is an entity which the Reporting Person controls. Read SEC document |
| May 01, 2023 Filed May 19, 2023 18:06 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | GrantStock options · Derivative | 125,000 | $0.00 Strike: $1.26 | $0.00 |
DisclosureSEC source: 0001731122-23-000987 · ownership.xml · derivative · entry 1 Caple Frederick William · CIK 0001978199 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By SNS Universal Solutions, LLC Disclosed balance after: 125,000 Underlying: Common stock · 125,000 shares Expires 2033-05-01 F1 · derivative.exercise_date: The options are being issued in connection with serving on the board of directors of SBEV, pursuant to the 2020 Long-Term Incentive Compensation Plan. 10,417 options will vest on the 1st day of each month starting June 2023 until January 2024 and 10,416 options will vest on the 1st day of each month starting February 2024 until May 2024. F2 · ownership.nature: The Stock Options are issued to SNS Universal Solutions, LLC of which Frederick William Caple is the principle. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.